The overall goal of this proposal is to better understand how natural killer (NK) cells control viral infections. It is clear that NK cells play a vital role in early, innate immunity against pathogens, especially herpesviruses, such as cytomegalovirus (CMV). CMV is an important human pathogen, particularly in immunocompromised patients such as those with HIV/AIDS and transplant recipients. Moreover, humans with a selective deficiency in NK cells suffer from recurrent viral infections, including CMV. However, human CMV cannot be studied in small animal models for more detailed analysis of how NK cells control this virus. But studies of murine CMV (MCMV), a natural pathogen of mice, recapitulates many features of HCMV infection. Prior studies clearly indicate that a central component of how NK cell control MCMV in C57BL/6 mice is the NK cell activation receptor, Ly49H, which recognizes m157, encoded by MCMV. The interaction between Ly49H and m157 is required for effective control and survival from infection. However, in the absence of inflammation, Ly49H+ NK cells are not activated, suggesting that NK cells must receive other signals, perhaps from cytokines, in order to become efficient effector cells. Moreover, the initially infected cell is a reticular fibroblast in the spleen which produces cytokines and chemokines that appear to initiate the immune response and may affect NK cell functions. How these cells are activated by MCMV is not known but available evidence from the study of other viruses suggest that they may use a cytosolic sensor to detect the virus and stimulate cytokine production. But the role of cytosolic sensors for large DNA viruses like MCMV has not been established. Therefore, the specific aims of this proposal are to: 1) Determine mechanism by which initially infected cells respond to MCMV infection. 2) Determine intravital behavior of virus-specific NK cells with MCMV-infected cells. 3) Examine cytokine second signals for NK cells to be effectively activated by targets. These studies will provide significant insight into the molecular basis for host anti-viral defense in innate immunity provided by NK cells.

Public Health Relevance

cytomegalovirus (CMV) is an important human pathogen, particularly in patients with HIV/AIDS and transplant recipients, and it is a leading cause of congenital disease. The immune system protects the body from infections but how it controls CMV is poorly understood. This project aims to better understand how a component of the immune system, the natural killer cell, controls a related virus, murine CMV, because of the availability of experimental tools that will allow major progress and insight.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI051345-12
Application #
8390464
Study Section
Immunity and Host Defense Study Section (IHD)
Program Officer
Beisel, Christopher E
Project Start
2002-03-01
Project End
2017-04-30
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
12
Fiscal Year
2013
Total Cost
$285,760
Indirect Cost
$97,760
Name
Washington University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Chapa, Travis J; Johnson, L Steven; Affolter, Christopher et al. (2013) Murine cytomegalovirus protein pM79 is a key regulator for viral late transcription. J Virol 87:9135-47
Elliott, Julie M; Yokoyama, Wayne M (2011) Unifying concepts of MHC-dependent natural killer cell education. Trends Immunol 32:364-72
Vivier, Eric; Raulet, David H; Moretta, Alessandro et al. (2011) Innate or adaptive immunity? The example of natural killer cells. Science 331:44-9
Cooper, Megan A; Yokoyama, Wayne M (2010) Memory-like responses of natural killer cells. Immunol Rev 235:297-305
Cheng, Tammy P; Valentine, Mark C; Gao, Jian et al. (2010) Stability of murine cytomegalovirus genome after in vitro and in vivo passage. J Virol 84:2623-8
Higuchi, D A; Cahan, P; Gao, J et al. (2010) Structural variation of the mouse natural killer gene complex. Genes Immun 11:637-48
Hsu, Kimberly M; Pratt, Jennifer R; Akers, Walter J et al. (2009) Murine cytomegalovirus displays selective infection of cells within hours after systemic administration. J Gen Virol 90:33-43
Zafirova, Biljana; Mandaric, Sanja; Antulov, Ronald et al. (2009) Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice. Immunity 31:270-82
Cooper, Megan A; Colonna, Marco; Yokoyama, Wayne M (2009) Hidden talents of natural killers: NK cells in innate and adaptive immunity. EMBO Rep 10:1103-10
Cooper, Megan A; Elliott, Julie M; Keyel, Peter A et al. (2009) Cytokine-induced memory-like natural killer cells. Proc Natl Acad Sci U S A 106:1915-9

Showing the most recent 10 out of 13 publications